Literature DB >> 8475365

Determination of chromium in blood and serum: evaluation of quality control procedures and estimation of reference values in Danish subjects.

J M Christensen1, E Holst, J P Bonde, L Knudsen.   

Abstract

This paper describes analytical methods to estimate environmental and occupational exposure levels of chromium in blood and serum by Zeeman atomic absorption spectrometry. Also reported is an internal quality control procedure involving a combination of an online quality control and subsequent statistical evaluation of the quality control results to evaluate the performance of the analytical methods. The solubilization of the blood by the proteinase Subtilisin A resulted in a recovery of chromium of 106 +/- 4.5%; the uncertainty was approximately 10% at a chromium level of 1 microgram l-1. The detection limit (LOD) for chromium in serum was 0.17 micrograms l-1 and 0.20 micrograms l-1 for chromium in blood. The LODs were sufficiently low for the determination of chromium in a large fraction of reference populations not occupationally exposed. The present study indicates that reference values for chromium in blood and serum are low but within the range in recent investigations, i.e. 0.04-0.35 micrograms l-1 in serum and 0.12-0.34 micrograms l-1 in human whole blood. The fraction of reference values below LOD was between 0.45 and 0.57 for chromium in serum and blood. Consequently, the reference populations were described by distribution free one-sided tolerance intervals and the precision of the estimation of the tolerance intervals was expressed as coverage intervals. The 95% one-sided tolerance limit calculated for chromium in serum was 0.60 micrograms l-1 with the coverage interval (95 +/- 4.8) percent at a probability of 0.95. Thus, the probability was 0.975 that the tolerance interval covers at least 90.2% of the distribution. In addition, the probability was 0.025 that the tolerance interval covers more than 99.8% of the population. It was only possible to calculate the 90% tolerance interval for chromium in blood with the coverage interval at 0.90 probability. The one-sided tolerance interval for chromium in blood was 0.37 micrograms l-1 with the coverage interval (90 +/- 9.9) percent at a probability of 0.90.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475365     DOI: 10.1016/0048-9697(93)90258-8

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  A short-term cross-over study on oral administration of soluble and insoluble cobalt compounds: sex differences in biological levels.

Authors:  J M Christensen; O M Poulsen; M Thomsen
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

2.  Biomonitoring of cadmium, chromium, nickel and arsenic in general population living near mining and active industrial areas in Southern Tunisia.

Authors:  Rim Khlifi; Pablo Olmedo; Fernando Gil; Molka Feki-Tounsi; Bouthaina Hammami; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  Environ Monit Assess       Date:  2014-02       Impact factor: 2.513

3.  Heavy Metals in the Blood Serum and Feces of Mugger Crocodile (Crocodylus palustris) in Sistan and Baluchistan Province, Iran.

Authors:  Amin Gholamhosseini; Mahdi Banaee; Siyavash Soltanian; Fahimeh Sakhaie
Journal:  Biol Trace Elem Res       Date:  2021-09-18       Impact factor: 3.738

4.  Determination of the urinary metabolites of styrene: estimation of the method evaluation function and evaluation of reference values in Danish subjects.

Authors:  A J Mürer; J M Christensen; T Midtgaard
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

Review 5.  Adverse hematological effects of hexavalent chromium: an overview.

Authors:  Rina Rani Ray
Journal:  Interdiscip Toxicol       Date:  2017-05-17

6.  Chromium in Postmortem Material.

Authors:  Danuta Dudek-Adamska; Teresa Lech; Tomasz Konopka; Paweł Kościelniak
Journal:  Biol Trace Elem Res       Date:  2018-04-17       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.